Showing results (1-10 of 99) with videos related to
Sort By:
Pageof 10
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Peptide aptamers for small molecule drug discoveryCarine Bardou, Christophe Borie, Marc Bickle, et al.Molecular & Cellular Proteomics : MCP|December 6, 2006
An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activityBenoît de Chassey, Ivan Mikaelian, Anne-Laure Mathieu, et al.Molecular & Cellular Proteomics : MCP|April 13, 2013
Calcineurin A versus NS5A-TP2/HD domain containing 2: a case study of site-directed low-frequency random mutagenesis for dissecting target specificity of peptide aptamersSilvia Dibenedetto, David Cluet, Pierre-Nicolas Stebe, et al.Antiviral Research|May 12, 2009
Inhibition of vaccinia virus replication by peptide aptamersLaurent Saccucci, Jean-Marc Crance, Pierre Colas, et al.Molecular & Cellular Proteomics : MCP|September 6, 2007
A comparative analysis of perturbations caused by a gene knock-out, a dominant negative allele, and a set of peptide aptamersNadia Abed, Marc Bickle, Bernard Mari, et al.Antiviral Research|August 14, 2012
A small molecule screen in yeast identifies inhibitors targeting protein-protein interactions within the vaccinia virus replication complexOlivier Flusin, Laurent Saccucci, Céline Contesto-Richefeu, et al.Analytical and Bioanalytical Chemistry|June 26, 2010
The beautiful cell: high-content screening in drug discoveryMarc BickleCombinatorial Chemistry & High Throughput Screening|March 26, 2014
The technology development studio of the MPI-CBG: an open access cell-based screening facilityMarc BickleIdrugs : the Investigational Drugs Journal|November 7, 2008
High-content screening: a new primary screening tool?Marc BickleExpert Opinion on Drug Discovery|July 26, 2012
Systems drug discovery: a quantitative, objective approach for safer drug developmentMarc BicklePageof 10